Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex
Patent
1997-12-15
2000-05-02
Lankford, Jr., Leon B.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Conjugate or complex
4352351, 514732, 514738, A61K 3105, A61K 3112
Patent
active
060569611
ABSTRACT:
The use of extracts from the plant Hypericum perforatum in the preparation of pharmaceutical compositions for the treatment of hepatitis C, chronic hepatitis C and related viruses, said pharmaceutical compositions comprising at least one extract of the plant Hypericum perforatum and optionally in addition, one or more pharmaceutically acceptable inactive components, selected from, carriers, coatings, diluents and adjuvants.
REFERENCES:
patent: 4704281 (1987-11-01), Elthes et al.
patent: 4898891 (1990-02-01), Lavie et al.
patent: 5834443 (1998-11-01), Masiello
S. Chris Pappas, Jay H. Hoofnagle, Neal Young, Stephen E. Straus, and E. Anthony Jones, Treatment of Chronic Non-A, Non-B Hepatitis With Acyclovir: Pilot Study, Journal of Medical Virology 15:1-9 (1985).
Edward Tabor, Kenichi Kobayashi, Hepatitis C Virus, a Causative Infectious Agent of Non-A, Non-B Hepatitis: Prevalance and Structure--Summary of a Conference on Hepatitis C Virus as a Cause of Hepatocellular Carcinoma, Journal of the National Cancer Institute vol. 84:86-90 (1992).
Qui-Lim Choo, George Kuo, Amy J. Weiner, lacy R. Overby, Daniel W. Bradley, Michael Houghton, Isolation of a cDNA Clone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome, Science, vol. 244:359-362 (1989).
Saez-Royuela, F, JC Porres, A Moreno, I Castillo, G Martinez, F Gallana and V Carreno. 1991, High Doses of Recombinant Alfa-Interferon or Gamma-Interferon for Chronic Hepatitis C: A Randomized Controlled Hepatology 13: 327-331.
Dusheiko G and P, Simmons 1994. Sequence Variability of Hepatitis C Virus and its Clinical Significance (Review, J. Viral Hepatitis 1: 3-15.
Kanai K, M Kato and H Okamoto 1992, HCV genotypes in chronic hepatitis C and response to interferon, Lancet 339: 1543.
Yoshioka K, S Kakumu, T Wakita et al. 1992, Detection of hepatitis C virus by polymerase chain reaction and response to IFN-a therapy: relationship to genotypes of hepatitis C virus, Hepatology 16: 293-299.
Kakumu S., Yoshioka K., Wakita T., Ishikawa T., Takayanagi M, and Higashi Y. A pilot study of Ribavirin and interferon beta for the treatment of chronic hepatitis C. Gastroenterology 1993, 105: 507-512.
Moraleda G, TT Wu, AR Jilbert, CE Aldrich, LD Condreay. SH Larsen, JC Tang, M Colacino, WS Mason, 1993: Inhibition of duck hepatitis B virus replication by hypericin. Antiviral Res. 20: 235-247.
Lavie, G, F. Valentine, B. Levin, Y. Mazur, G. Gallo, D. Lavie, D. Weiner, D. Meruelo, 1989: studies of the mechanisms of action of the antiretroviral agents hypericin and pseudohypericin. Proc. Natl. Acad. Sci. (USA) 86: 5963-5967.
"Hypericin Vimrxyn", Drugs of the Future, vol. 21, No. 5, 1996, pp. 555-556.
Gloria Moraleda, et al., "Inhibition of Duck Hepatitis B Virus Replication by Hypericin", Antiviral Research, vol. 20, No. 3, Mar. 1993, pp. 235-247.
Tyler. Herbs of Choice. 1994. pp. 122-124, 1994.
Kinghorn et al. Human Medicinal Agents from Plants, p. 32, 1993.
Lavie David
Steinbeck-Klose Anne
LandOfFree
Plant extracts for the preparation of pharmaceutical composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Plant extracts for the preparation of pharmaceutical composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Plant extracts for the preparation of pharmaceutical composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1592006